[Activity Report] Launch of New Website by AMED Public and Private Partnerships for Infectious Disease R&D (April 14, 2022)
date : 4/27/2022
Tags: AMR
![[Activity Report] Launch of New Website by AMED Public and Private Partnerships for Infectious Disease R&D (April 14, 2022)](https://hgpi.org/en/wp-content/uploads/sites/2/AMRalliance-logo-11-20.jpg){kind=logo}
A new website has been created by the AMED Public and Private Partnerships for Infectious Disease R&D, an initiative put together by AMED as well as the Japan Association for Infectious Diseases, the Japanese Society of Chemotherapy, and the Japan Pharmaceutical Manufacturers Association (JPMA) among others. The last three organizations are all AMR Alliance Japan members.
The new website features a set of policy recommendations developed by Health and Global Policy Institute (HGPI) via the Nikkei FT Communicable Diseases Conference Asia Africa Medical Innovation Consortium (AMIC) AMR Consortium (Secretariat: AMR Alliance Japan) on the creation of a pull incentive for antimicrobials in Japan.
HGPI and AMR Alliance Japan will continue to partner with public and private stakeholders such as the AMED Public and Private Partnerships for Infectious Disease R&D to promote solutions to infectious disease issues including AMR.
Top Research & Recommendations Posts
- [Public Comment Submission] “Basic Plan for the Promotion of Cancer Control (Draft)” (February 18, 2023)
- [Urgent Recommendations] Challenges and Prospects for the Implementation and Execution of the Basic Law and Basic Policy for Child and Maternal Health and Development (February 17, 2023)
- [Research Report] Building a Mental Health Program for Children and Measuring its Effectiveness (June 16, 2022）
- [Publication Report] The Children’s Health Project Publishes Family Mental Health Booklet “Nurturing Child and Guardian Mental Health through Our Communication with Children” in Five Languages (February 6, 2023)
- [Policy Recommendations] Four Perspectives on Advancing Measures for Idiopathic Normal Pressure Hydrocephalus (iNPH) (February 16, 2023)
Featured Posts
-
2022-12-26
[Event Report] The Health and Global Policy Institute Chronic Disease Control Project Holds Advisory Board Meeting for “Engaging and Cooperating with Patients, Citizens, and Communities for Obesity Prevention” (September 22, 2022)
![[Event Report] The Health and Global Policy Institute Chronic Disease Control Project Holds Advisory Board Meeting for “Engaging and Cooperating with Patients, Citizens, and Communities for Obesity Prevention” (September 22, 2022)](https://hgpi.org/en/wp-content/uploads/sites/2/ncd-ob-20220922-top.jpg)
-
2023-03-06
[In the Media] What Healthy Climate Prescription Teaches Us: Health Care’s Approach to the Climate Crisis (Min-Iren Iryo, No. 606; February 24, 2023)
![[In the Media] What Healthy Climate Prescription Teaches Us: Health Care’s Approach to the Climate Crisis (Min-Iren Iryo, No. 606; February 24, 2023)](https://hgpi.org/en/wp-content/uploads/sites/2/lecture-media-210-top.png)
-
2023-03-09
[Event Report] HGPI Special Seminar – Universal Health Coverage in an Era of Antimicrobial Resistance (August 18, 2022)
![[Event Report] HGPI Special Seminar – Universal Health Coverage in an Era of Antimicrobial Resistance (August 18, 2022)](https://hgpi.org/en/wp-content/uploads/sites/2/uhc-shs-20220818-1-top_JPNENG.jpg)
-
2023-03-15
[Event Report] The Cardiovascular Disease Control Promotion Project, Phase 2. “Current Issues and Prospects for Advancing Cardiovascular Disease Control Promotion Plans in Each Prefecture” (March 15, 2023)
![[Event Report] The Cardiovascular Disease Control Promotion Project, Phase 2. “Current Issues and Prospects for Advancing Cardiovascular Disease Control Promotion Plans in Each Prefecture” (March 15, 2023)](https://hgpi.org/en/wp-content/uploads/sites/2/ncd-cd-20230315-top-scaled-1.jpg)
